Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (936) 936
Publication (100) 100
Newsletter (16) 16
Book Review (11) 11
Book Chapter (6) 6
Magazine Article (6) 6
Conference Proceeding (5) 5
Book / eBook (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (698) 698
index medicus (546) 546
rotavirus infections - prevention & control (414) 414
rotavirus (386) 386
vaccines (385) 385
infant (382) 382
immunology (346) 346
children (329) 329
diarrhea (318) 318
rotavirus vaccines - therapeutic use (302) 302
child, preschool (266) 266
vaccination (265) 265
viruses (265) 265
gastroenteritis (254) 254
medicine, research & experimental (244) 244
immunization (237) 237
female (235) 235
male (222) 222
rotavirus infections - epidemiology (215) 215
infants (201) 201
animals (194) 194
allergy and immunology (160) 160
rotavirus - immunology (155) 155
infectious diseases (151) 151
efficacy (144) 144
gastroenteritis - prevention & control (143) 143
child (135) 135
pediatrics (133) 133
disease (130) 130
rotavirus vaccines - immunology (129) 129
infant, newborn (126) 126
vaccine (126) 126
analysis (124) 124
health aspects (123) 123
safety (123) 123
gastroenteritis - virology (118) 118
mortality (114) 114
rotavirus vaccines - administration & dosage (114) 114
rotavirus infections - immunology (112) 112
prevention (111) 111
united-states (108) 108
infections (106) 106
diarrhea - virology (105) 105
rotavirus infections (105) 105
infection (101) 101
rotavirus vaccine (101) 101
gastroenteritis - epidemiology (99) 99
rotavirus infections - virology (99) 99
surveillance (98) 98
epidemiology (96) 96
public health (94) 94
age (92) 92
research (91) 91
diarrhea - prevention & control (89) 89
children & youth (87) 87
microbiology (86) 86
rotavirus vaccines - adverse effects (85) 85
studies (84) 84
vaccines, attenuated - therapeutic use (83) 83
hospitalization (82) 82
medical research (80) 80
cost-effectiveness (75) 75
research article (75) 75
developing countries (71) 71
intussusception (71) 71
proteins (71) 71
medicine (70) 70
pharmacology & pharmacy (70) 70
rotavirus - genetics (69) 69
rotavirus vaccines - economics (69) 69
rotavirus vaccines (66) 66
mice (65) 65
hospitals (64) 64
medicine, experimental (64) 64
diarrhea - epidemiology (63) 63
double-blind (63) 63
impact (63) 63
young-children (63) 63
clinical trials (60) 60
article (59) 59
immunogenicity (59) 59
hospitalization - statistics & numerical data (58) 58
medicine, general & internal (58) 58
cost-benefit analysis (55) 55
viral vaccines - therapeutic use (54) 54
adult (53) 53
care and treatment (52) 52
burden (51) 51
rotavirus infections - economics (51) 51
vaccines, attenuated - immunology (50) 50
virus diseases (50) 50
rotavirus - isolation & purification (49) 49
rotavirus vaccination (49) 49
virology (49) 49
antigens (48) 48
incidence (48) 48
multidisciplinary sciences (48) 48
acute gastroenteritis (47) 47
treatment outcome (45) 45
usage (45) 45
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (932) 932
French (9) 9
German (8) 8
Italian (4) 4
Polish (4) 4
Chinese (2) 2
Portuguese (2) 2
Russian (2) 2
Hebrew (1) 1
Japanese (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Vaccines for preventing rotavirus diarrhoea: vaccines in use
by Soares-Weiser, Karla and Maclehose, Harriet and Bergman, Hanna and Ben-Aharon, Irit and Nagpal, Sukrti and Goldberg, Elad and Pitan, Femi and Cunliffe, Nigel
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2, Issue 11, p. CD008521
Background Rotavirus results in more diarrhoea-related deaths in children less than five years of age than any other single agent in countries with high... 
UNITED-STATES | WORLD-WIDE DEVELOPMENT | Rotavirus Infections [prevention & control] | Rotavirus Vaccines [therapeutic use] | ORAL POLIOVIRUS VACCINE | Randomized Controlled Trials as Topic | Vaccines, Attenuated [therapeutic use] | HEALTHY INFANTS | MEDICINE, GENERAL & INTERNAL | 1ST 2 YEARS | RANDOMIZED-CONTROLLED-TRIALS | Diarrhea [prevention & control; virology] | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Infant, Newborn | DEVELOPING-COUNTRIES | ROUTINE INFANT VACCINES | Humans | Diarrhea - virology | Child, Preschool | Diarrhea - prevention & control | Infant | Vaccines, Attenuated - therapeutic use | Rotavirus Vaccines - therapeutic use | Rotavirus Infections - prevention & control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Vaccines for preventing rotavirus diarrhoea: Vaccines in use
by Soares-Weiser, Karla and Bergman, Hanna and Henschke, Nicholas and Pitan, Femi and Cunliffe, Nigel
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2019, Volume 2019, Issue 3, p. CD008521
Background Rotavirus results in more diarrhoea-related deaths in children under five years than any other single agent in countries with high childhood... 
INTUSSUSCEPTION RISK | Diarrhea, Infantile [prevention & control virology] | WORLD-WIDE DEVELOPMENT | DOSE-ESCALATION SAFETY | Humans | Rotavirus Infections [prevention & control] | RANDOMIZED CLINICAL-TRIAL | Rotavirus Vaccines [therapeutic use] | Infant | ORAL POLIOVIRUS VACCINES | Vaccines Attenuated [therapeutic use] | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | 1ST 2 YEARS | Diarrhea [prevention & control; virology] | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Infant, Newborn | SOUTH-AFRICAN CHILDREN | ROUTINE INFANT VACCINES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial
by Bhandari, Nita, PhD and Rongsen-Chandola, Temsunaro, MSc and Bavdekar, Ashish, DNB and John, Jacob, MD and Antony, Kalpana, MBA and Taneja, Sunita, PhD and Goyal, Nidhi, DPH and Kawade, Anand, MD and Kang, Gagandeep, Prof and Rathore, Sudeep Singh, MBBS and Juvekar, Sanjay, PhD and Muliyil, Jayaprakash, Prof and Arya, Alok, MPharm and Shaikh, Hanif, MPharm and Abraham, Vinod, MPH and Vrati, Sudhanshu, Prof and Proschan, Michael, PhD and Kohberger, Robert, PhD and Thiry, Georges, PhD and Glass, Roger, PhD and Greenberg, Harry B, Prof and Curlin, George, MD and Mohan, Krishna, PhD and Harshavardhan, G V J A, BVSc and Prasad, Sai, MBA and Rao, T S, PhD and Boslego, John, MD and Bhan, Maharaj Kishan, Dr Prof and India Rotavirus Vaccine Grp and India Rotavirus Vaccine Group
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9935, pp. 2136 - 2143
Summary Background Rotavirus is the most common cause of severe dehydrating gastroenteritis in developing countries. Safe, effective, and affordable rotavirus... 
Internal Medicine | RRV-TV | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | 1ST 2 YEARS | PROTECTION | SAFETY | INFECTION | GASTROENTERITIS | CONFIDENCE | CHILDREN | POLIO | Double-Blind Method | Humans | Female | Infant | Male | Gastroenteritis - prevention & control | Rotavirus Vaccines - therapeutic use | India | Rotavirus Infections - prevention & control | Usage | Vaccines | Research | Analysis | Rotaviruses | Immunization | Mortality | Diarrhea | Viruses | Developing countries--LDCs | Children & youth
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effectiveness of rotavirus vaccination: A systematic review of the first decade of global postlicensure data, 2006-2016
by Jonesteller, Christine L and Burnett, Eleanor and Yen, Catherine and Tate, Jacqueline E and Parashar, Umesh D
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 65, Issue 5, pp. 840 - 850
Two rotavirus vaccines, Rotarix (RV1) and RotaTeq (RV5), were licensed for global use in 2006. A systematic review of 48 peer-reviewed articles with... 
Rotavirus vaccine | Vaccine effectiveness | INFECTIOUS DISEASES | MALAWIAN CHILDREN | rotavirus vaccine | ACUTE GASTROENTERITIS | MICROBIOLOGY | IMMUNOLOGY | IMMUNIZATION INFORMATION-SYSTEM | vaccine effectiveness | DOUBLE-BLIND | MONOVALENT | SUSTAINED EFFECTIVENESS | US CHILDREN | PENTAVALENT | SOUTH-AFRICAN CHILDREN | VACCINES | Rotavirus Infections - epidemiology | Humans | Child, Preschool | Infant | Vaccination - statistics & numerical data | Vaccines, Attenuated - administration & dosage | Vaccines, Attenuated - therapeutic use | Developing Countries | Rotavirus Vaccines - therapeutic use | Child | Infant, Newborn | Rotavirus Vaccines - administration & dosage | Rotavirus Infections - prevention & control | Care and treatment | Usage | Rotavirus infections | Vaccination | Patient outcomes | Analysis | Infants
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
by Patel, Manish M, Dr and Glass, Roger, PhD and Desai, Rishi, MD and Tate, Jacqueline E, PhD and Parashar, Umesh D, MBBS
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 7, pp. 561 - 570
Summary Rotavirus is the most common cause of fatal and severe childhood diarrhoea worldwide. Two new rotavirus vaccines have shown efficacy against severe... 
Infectious Disease | UNITED-STATES | INFECTIOUS DISEASES | DIARRHEA-ASSOCIATED HOSPITALIZATIONS | 1ST 2 YEARS | CHILDHOOD DIARRHEA | GASTROENTERITIS HOSPITALIZATIONS | SUSTAINED DECLINE | DOUBLE-BLIND | ORAL POLIOVIRUS VACCINE | LESS-THAN-5 YEARS | DEVELOPING-COUNTRIES | Diarrhea - mortality | Humans | Diarrhea - virology | Rotavirus - immunology | Rotavirus Vaccines - adverse effects | Diarrhea - prevention & control | Rotavirus Vaccines - therapeutic use | Rotavirus Infections - prevention & control | Vaccination | Vaccines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants
by Taniuchi, Mami and Platts-Mills, James A and Begum, Sharmin and Uddin, Md Jashim and Sobuz, Shihab U and Liu, Jie and Kirkpatrick, Beth D and Colgate, E. Ross and Carmolli, Marya P and Dickson, Dorothy M and Nayak, Uma and Haque, Rashidul and Petri, William A and Houpt, Eric R
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 27, pp. 3068 - 3075
Highlights • Oral vaccines exhibit poor performance in low-income settings. • Enterovirus and Campylobacter carriage are associated with lower OPV... 
Allergy and Immunology | Rotavirus vaccine | Oral polio vaccine | Vaccine immunogenicity | Enteric infections | PCR | Vaccine efficacy | MEDICINE, RESEARCH & EXPERIMENTAL | DIARRHEA | ASSAY | IMMUNOLOGY | IDENTIFICATION | FAILURE | TROPICS | CHILDREN | REAL-TIME PCR | STOOL | POLYMERASE-CHAIN-REACTION | CAMPYLOBACTER | Poliovirus Vaccine, Oral - therapeutic use | Humans | Child, Preschool | Infant | Male | Enterovirus | Antibodies, Viral - blood | Bangladesh | Campylobacter Infections - immunology | Enterovirus Infections - immunology | Immunoglobulin A - blood | Female | Vaccines, Attenuated - therapeutic use | Feces | Rotavirus Vaccines - therapeutic use | Antibodies, Neutralizing - blood | Campylobacter | Medical colleges | Infants | Vaccines | Communicable diseases | Evaluation | Medical research | Poliomyelitis | Medicine, Experimental | Health aspects | Public health | Low income groups | Studies | Immunization | Diarrhea | Viruses | Infections | Regression analysis | Age | Deoxyribonucleic acid--DNA | Shipments | RV, rotavirus vaccine | EV, enterovirus | EIEC, enteroinvasive E. coli | OPV, oral polio vaccine | IPV, inactivated poliovirus vaccine | STEC, Shiga-toxin producing E. coli | TAC, TaqMan Array Card | PROVIDE, Performance of Rotavirus and Oral Polio Vaccines in Developing Countries | EPEC, enteropathogenic E. coli | NPEV, non-polio enterovirus | ETEC, enterotoxigenic E. coli | EAEC, enteroaggregative E. coli
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effectiveness of pentavalent rotavirus vaccine against severe disease
by Staat, Mary Allen and Payne, Daniel C and Donauer, Stephanie and Weinberg, Geoffrey A and Edwards, Kathryn M and Szilagyi, Peter G and Griffin, Marie R and Hall, Caroline B and Curns, Aaron T and Gentsch, Jon R and Salisbury, Shelia and Fairbrother, Gerry and Parashar, Umesh D and NVSN and New Vaccine Surveillance Network (NVSN) and the New Vaccine Surveillance Network (NVSN)
Pediatrics, ISSN 0031-4005, 08/2011, Volume 128, Issue 2, pp. e267 - e275
OBJECTIVE: To determine the vaccine effectiveness (VE) of complete and partial vaccination with the pentavalent rotavirus vaccine (RV5) in the prevention of... 
RV5 | Vaccine impact | Rotavirus | Population-based surveillance | Vaccine effectiveness | Acute gastroenteritis | UNITED-STATES | COST-EFFECTIVENESS | EFFICACY | population-based surveillance | PREVENTION | GASTROENTERITIS | vaccine effectiveness | rotavirus | PEDIATRICS | POLYMERASE CHAIN-REACTION | HOSPITALIZATIONS | vaccine impact | acute gastroenteritis | RESPIRATORY SYNCYTIAL VIRUS | YOUNG-CHILDREN | Severity of Illness Index | Gastroenteritis - epidemiology | Prospective Studies | Rotavirus Infections - epidemiology | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Gastroenteritis - prevention & control | Case-Control Studies | Rotavirus Vaccines - genetics | Female | Vaccines, Attenuated - therapeutic use | Rotavirus Infections - pathology | Rotavirus Vaccines - therapeutic use | Gastroenteritis - pathology | Rotavirus Infections - prevention & control | Vaccines, Attenuated - genetics | Prevention | Usage | Viral vaccines | Rotavirus infections | Gastroenteritis | Dosage and administration | Research | Pediatrics | Immunization | Vaccines | Gastroenterology | Effectiveness studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rotavirus vaccine: a single birth dose?
by Barnes, Graeme L
The Lancet Infectious Diseases, ISSN 1473-3099, 07/2018, Volume 18, Issue 7, pp. 714 - 715
[...]lower gastric acid in newborns, and administration during the early stage of microbial gut colonisation, are likely to facilitate immunisation.3,4... 
INFECTIOUS DISEASES | INFECTION | INFANTS | CHILDREN | RV3-BB | Rotavirus Infections - drug therapy | Humans | Female | Immunization Schedule | Infant | Male | Vaccines, Attenuated - therapeutic use | Secondary Prevention | Rotavirus Vaccines - therapeutic use | Infant, Newborn | Clinical trials | Diarrhea | Viruses | Infections | Vaccines | Newborn babies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text RotaTeq® , a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe
by Vesikari, Timo and Itzler, Robbin and Karvonen, Aino and Korhonen, Tiina and Van Damme, Pierre and Behre, Ulrich and Bona, Gianni and Gothefors, Leif and Heaton, Penny M and Dallas, Michael and Goveia, Michelle G and Medicinska fakulteten and Institutionen för klinisk vetenskap and Pediatrik and Umeå universitet
Vaccine, ISSN 0264-410X, 2009, Volume 28, Issue 2, pp. 345 - 351
Abstract A pentavalent human–bovine reassortant oral rotavirus vaccine, RotaTeq® , was evaluated among nearly 70,000 infants in the Rotavirus Efficacy and... 
Allergy and Immunology | Infantile acute gastroenteritis | Randomized controlled trial | Rotavirus vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | IMMUNOLOGY | REVEAL | GASTROENTERITIS | CHILDREN | HEALTHY INFANTS | SEASONALITY | IMMUNOGENICITY | DISEASE | BURDEN | Rotavirus Infections - immunology | Europe | Humans | Rotavirus Vaccines - adverse effects | Infant | Vaccines, Attenuated - therapeutic use | Gastroenteritis - virology | Gastroenteritis - prevention & control | Rotavirus Vaccines - therapeutic use | Vaccines, Attenuated - adverse effects | Gastroenteritis - immunology | Rotavirus Infections - prevention & control | Diarrhea | Hospitalization | Hospitals | Vaccines | Children & youth | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Challenges in mucosal vaccines for the control of infectious diseases
by Azegami, Tatsuhiko and Yuki, Yoshikazu and Kiyono, Hiroshi
International Immunology, ISSN 0953-8178, 2014, Volume 26, Issue 9, pp. 517 - 528
The mucosal surface is the largest route through which pathogens enter the human body. To control the outbreak of mucosal infectious diseases, we must use our... 
Oral vaccine | MucoRice | Rice-based vaccine | Nasal vaccine | INFLUENZA-VIRUS VACCINE | ESCHERICHIA-COLI | SALMONELLA-TYPHI | IMMUNOLOGY | 1ST 2 YEARS | IMMUNE-RESPONSES | ORAL CHOLERA VACCINES | LABILE ENTEROTOXIN | nasal vaccine | HUMAN ROTAVIRUS VACCINE | DOUBLE-BLIND | rice-based vaccine | oral vaccine | T-CELLS | Cholera Vaccines - immunology | Vibrio cholerae - immunology | Humans | Cholera Vaccines - therapeutic use | Salmonella typhi - immunology | Cholera - prevention & control | Immunity, Mucosal - drug effects | Animals | Salmonella Vaccines - immunology | Salmonella Vaccines - therapeutic use | Typhoid Fever - prevention & control | Cholera - immunology | Typhoid Fever - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights